Who may benefit from oral anticoagulation following an embolic stroke of undetermined source?
{{output}}
Embolic stroke of undetermined source (ESUS) represents up to one-sixth of ischemic strokes and is associated with an annual recurrence risk of 4%-5% despite contemporary secondary prevention. The hypothesis that oral anticoagulation would reduce recurrence co... ...
